SCHEDULE: Helius Medical: CVI Investments Divests All Shares

Sentiment:

Schedule 13G Amendment


CVI Investments, Inc. and Heights Capital Management, Inc. have reported zero beneficial ownership in Helius Medical Technologies, Inc. Class A Common Stock.

Worse than expectedA significant institutional investor, CVI Investments, Inc., along with its investment manager, Heights Capital Management, Inc., has fully divested its holdings, reducing beneficial ownership to 0%. This indicates a loss of confidence from a major holder.

Summary

  • This is an Amendment No. 1 to a Schedule 13G filing for Helius Medical Technologies, Inc.
  • CVI Investments, Inc. and Heights Capital Management, Inc. are the reporting persons.
  • The reporting persons now beneficially own 0% of Helius Medical Technologies, Inc.'s Class A Common Stock.
  • This indicates a complete divestment of their previous holdings in the company.
  • Heights Capital Management, Inc. serves as the investment manager for CVI Investments, Inc.

Sentiment

Score: 2

Explanation: The complete divestment by a significant institutional investor indicates a strong negative signal regarding their confidence in the company's future performance.

Negatives

  • CVI Investments, Inc. and Heights Capital Management, Inc. have reduced their beneficial ownership in Helius Medical Technologies, Inc. to 0%, indicating a complete divestment by a significant investor.

Stakeholder Impact

  • Shareholders may perceive the complete divestment by a significant investor as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.

Key Dates

DateDescription
06/30/2025Date of event which requires filing of this statement
08/12/2025Signature date of the filing

Recommendation

sell

The complete divestment by a previously significant institutional investor, CVI Investments, Inc., signals a strong lack of confidence in Helius Medical Technologies, Inc.'s future prospects. This action by a sophisticated investor suggests potential underlying issues or a belief that the stock will underperform, warranting a sell recommendation.

Keywords

Helius Medical Technologies, CVI Investments, Heights Capital Management, Schedule 13G, beneficial ownership, divestment, common stock, medical technology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.